The highly popular and useful FactorFirst card has been revised and the new version is now available for orders! Thank you to a great team...
Companies will likely make submissions to Health Canada for approval of gene therapies for hemophilia A and B in the next 6-12 months. To best...
Meet the CHS Board of Directors! From left to right: First row: Cyril Boulila, Wendy Quinn, Leanne Owen. Back row: Dr. Lawrence Jardine, Derek Klatt,...
CLICK HERE to read the official announcement from CHS President, Wendy Quinn.
Please CLICK HERE to access the 2021 CHS Annual Report. Should you want to consult the complete Financial Statements, you can do so by clicking...
